Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 2, 2008, Pages 345-348

  Lechner, Doris ^a   Gibbons, Simon ^b   Bucar, Franz ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Biochanin A; Efflux pumps; Isoflavonoids; Mycobacteria

Indexed keywords

ANTIMYCOBACTERIAL AGENT; BAICALEIN; BAICALIN; BIOCHANIN A; CHLORPROMAZINE; DAIDZEIN; EFFLUX PUMP INHIBITOR; ETHIDIUM BROMIDE; FORMONONETIN; ISOFLAVONE; ISONIAZID; LUTEOLIN; MYRICETIN; NATURAL PRODUCT; PHENOL DERIVATIVE; RESERPINE; RESVERATROL; STILBENE; VERAPAMIL;

ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; INHIBITION KINETICS; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; NONHUMAN;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; ENZYME INHIBITORS; ETHIDIUM; GENISTEIN; LUTEOLIN; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM SMEGMATIS; PHENOLS; STILBENES; VERAPAMIL;

EID: 47249085716     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn178     Document Type: Article

References (15)

1. WHO. XDR-TB Extensively drug-resistant tuberculosis. http://www.who.int/ tb/challenges/xdr/en/index.html (9 April 2008, date last accessed).
2. De Rossi E, Ainsa A Riccardi G. Role of mycobacterial efflux transporters in drug resistance: An unresolved question. FEMS Microbiol Rev 2006; 30: 36-52.
3. Cattoir V. Efflux-mediated antibiotics resistance in bacteria. Pathol Biol (Paris) 2004; 52: 607-16.
4. Lynch AS. Eff lux systems in bacterial pathogens: An opportunity for therapeutic intervention? An industry view. Biochem Pharmacol 2006; 71: 949-56.
5. Marquez B. Bacterial efflux systems and efflux pumps inhibitors. Biochimie 2005; 87: 1137-47.
6. Stavri M, Piddock LJV, Gibbons S. Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother 2007; 59: 1247-60.
7. Kaatz GW, Moudgal VV, Seo SM et al. Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47: 719-26.
8. Amaral L, Martins M, Viveiros; M. Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. J Antimicrob, Chemother 2007; 59: 1237-46.
9. Li X-Z, Zhang L, Nikaido H. Efflux pump-mectiated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob Agents Chemother 2004; 48: 2415-23.
10. Stavri M, Schneider R, O'Donnell G et al. The antimycobacterial components of hops (Humulus lupulus) and their dereplication. Phytother Res 2004; 18: 774-6.
11. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin Microbiol Infect 2000; 6: 503-8.
12. Kaatz GW, Seo SM, O'Brien L et al. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Antimicrob, Agents Chemother 2000; 44: 1404-6.
13. Parish T, Stoker NG. Electroporation of mycobacteria. Methods Mol Biol 1995; 47: 237-52.
14. Morel C, Stermitz FR, Tegos G et al. Isoflavones as potentiators of antibacterial activity. J Agric Food Chem 2003; 51: 5677-9.
15. Chung SY, Sung MK, Kim NH et al. Inhibition of P-glycoprotein by natural products in human breast cancer cells. Arch Pharmacal Res 2005; 28: 823-8.